As of press release, Brain Action Aurora-B has risen 14.23%. The company announced that on the evening of October 27, 2026, it received a Class II medical device registration certificate for cognitive function assessment software for patients with depression issued by the Beijing Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.